According to Stratistics MRC, the Global Sepsis Diagnostics market is accounted for $330.74 million in 2015 and is expected to reach $659.36 million by 2022 growing at a CAGR of 10.4%. This life-threatening condition of Sepsis arises when the body’s response to infection injures its own tissues and organs; the rise in number of the situations is demanding more diagnostics. Rising health concerns such as Cancer, Diabetes, Major Trauma, and Burns etc. are depleting the immune system among all age groups, which has given rise to the demand for the Sepsis diagnostics market. Moreover, increasing surgical procedures, exponential rise in incidence of hospital-acquired infections and growth in the number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness and shortage of skilled staff are the hindering the same.
Browse the full report @ http://www.orbisresearch.com/reports/index/sepsis-diagnostics-global-market-outlook-2016-2022 .
Blood Culture Media segment is expected to grow at par level owing to its standardized techniques for the Sepsis diagnostics. By Technology, Microbiology segment is estimated to be the largest growing segment in order to the increasing inclination of physicians and patients towards use of rapid diagnostic products for accurate and quick identification and diagnosis of sepsis. North America is dominating the global market owing to high prevalence of sepsis, rising number of invasive procedures, and rising government support towards sepsis researches. However, Asia Pacific is expected to be the fastest growing market owing to increasing number of surgical procedures, and growing number of clinical studies.
Some of the key players of the Sepsis Diagnostics market include Beckman Coulter (Danaher), Becton, Dickinson & Co. (BD), bioMérieux, Bio-Rad Laboratories, Bruker Corporation, Cepheid, Chembio Diagnostic Systems, Nanosphere, Inc., Ortho-Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, T2 Biosystems, Inc., Thermo Fisher Scientific, and Trinity Biotech.
Place a direct purchase order on this report @ http://www.orbisresearch.com/contact/purchase/184967 .
Rest of Europe
Rest of Asia Pacific
Rest of the World
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Request a sample to this report @ http://www.orbisresearch.com/contacts/request-sample/184967 .
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com